Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Glioblastoma 4Glioma 2Central Nervous System Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Meningioma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoma 1Brain Neoplasms 1

Interventions

pembrolizumab 2lenvatinib 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body × avelumab × CNS × Clear all
NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

NYU Langone Health

Phase 2 Completed
6 enrolled 10 charts
CNS

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡